A seventeen-year observation of the antimicrobial susceptibility of clinical Campylobacter jejuni and the molecular mechanisms of erythromycin-resistant isolates in Beijing, China

International Journal of Infectious Diseases

Volumn 42, Issue , 2016, Pages 28-33

  Zhou, Jiyuan ^a   Zhang, Maojun ^b,c   Yang, Wanna ^a   Fang, Yuqing ^a   Wang, Guiqiang ^a   Hou, Fengqin ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Campylobacter jejuni; Erythromycin; Molecular mechanism; Resistance

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; FLORFENICOL; GENOMIC DNA; GENTAMICIN; MACROLIDE; NALIDIXIC ACID; RIBOSOME RNA; RNA 23S; SPACER DNA; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; CHINA; DIARRHEA; ERMB GENE; FECES CULTURE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; NONHUMAN; RPLD GENE; RPLV GENE; ANIMAL; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST;

ANIMALS; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER JEJUNI; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84949571149     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.11.005     Document Type: Article

References (46)

1. Allos B.M. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001, 32:1201-1206.
2. Platts-Mills J.A., Kosek M. Update on the burden of Campylobacter in developing countries. Curr Opin Infect Dis 2014, 27:444-450.
3. Wilson D.J., Gabriel E., Leatherbarrow A.J., Cheesbrough J., Gee S., Bolton E., et al. Tracing the source of campylobacteriosis. PLoS Genet 2008, 4:e1000203.
4. Blaser M.J. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 1997, 176(Suppl 2):S103-S105.
5. Dasti J.I., Tareen A.M., Lugert R., Zautner A.E., Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol 2010, 300:205-211.
6. Pollett S., Rocha C., Zerpa R., Patino L., Valencia A., Camina M., et al. Campylobacter antimicrobial resistance in Peru: a ten-year observational study. BMC Infect Dis 2012, 12:193.
7. Ghosh R., Uppal B., Aggarwal P., Chakravarti A., Jha A.K. Increasing antimicrobial resistance of Campylobacter jejuni isolated from paediatric diarrhea cases in a tertiary care hospital of New Delhi. India. J Clin Diagn Res 2013, 7:247-249.
8. Bai Y., Cui S., Xu X., Li F. Enumeration and characterization of Campylobacter species from retail chicken carcasses in Beijing, China. Foodborne Pathog Dis 2014, 11:861-867.
9. Klena J.D., Parker C.T., Knibb K., Ibbitt J.C., Devane P.M., Horn S.T., et al. Differentiation of Campylobacter coli, Campylobacter jejuni, Campylobacter lari, and Campylobacter upsaliensis by a multiplex PCR developed from the nucleotide sequence of the lipid A gene lpxA. J Clin Microbiol 2004, 42:5549-5557.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard - third edition. CLSI document M31-A3. Wayne, PA: CLSI; 2008.
11. US Food and Drug Administration. National antimicrobial resistance monitoring system-enteric bacteria (NARMS): 2007 executive report. Rockville, MD: Department of Health and Human Services, US FDA; 2010.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement M100-S16. Wayne, PA: CLSI; 2007.
13. Vacher S., Menard A., Bernard E., Megraud F. PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. Antimicrob Agents Chemother 2003, 47:1125-1128.
14. Cagliero C., Mouline C., Cloeckaert A., Payot S. Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2006, 50:3893-3896.
15. Gibreel A., Kos V.N., Keelan M., Trieber C.A., Levesque S., Michaud S., et al. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother 2005, 49:2753-2759.
16. Lin J., Yan M., Sahin O., Pereira S., Chang Y.J., Zhang Q. Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens. Antimicrob Agents Chemother 2007, 51:1678-1686.
17. Duarte A., Santos A., Manageiro V., Martins A., Fraqueza M.J., Canica M., et al. Human, food and animal Campylobacter spp. isolated in Portugal: high genetic diversity and antibiotic resistance rates. Int J Antimicrob Agents 2014, 44:306-313.
18. Qin S., Wang Y., Zhang Q., Zhang M., Deng F., Shen Z., et al. Report of ribosomal RNA methylase gene erm(B) in multidrug-resistant Campylobacter coli. J Antimicrob Chemother 2014, 69:964-968.
19. Nichols G.L., Richardson J.F., Sheppard S.K., Lane C., Sarran C. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open 2012, 2. pii: e001179.
20. Mukherjee P., Ramamurthy T., Bhattacharya M.K., Rajendran K., Mukhopadhyay A.K. Campylobacter jejuni in hospitalized patients with diarrhea, Kolkata, India. Emerg Infect Dis 2013, 19:1155-1156.
21. Chen X., Naren G.W., Wu C.M., Wang Y., Dai L., Xia L.N., et al. Prevalence and antimicrobial resistance of Campylobacter isolates in broilers from China. Vet Microbiol 2010, 144:133-139.
22. Bester L.A., Essack S.Y. Prevalence of antibiotic resistance in Campylobacter isolates from commercial poultry suppliers in KwaZulu-Natal, South Africa. J Antimicrob Chemother 2008, 62:1298-1300.
23. Ma L., Wang Y., Shen J., Zhang Q., Wu C. Tracking Campylobacter contamination along a broiler chicken production chain from the farm level to retail in China. Int J Food Microbiol 2014, 181:77-84.
24. Wu Z., Sippy R., Sahin O., Plummer P., Vidal A., Newell D., et al. Genetic diversity and antimicrobial susceptibility of Campylobacter jejuni isolates associated with sheep abortion in the United States and Great Britain. J Clin Microbiol 2014, 52:1853-1861.
25. Albert M.J., Udo E., Jose B.T., Haridas S., Rotimi V.O. Tetracycline resistance is frequent among Campylobacter jejuni isolates from Kuwait. Microb Drug Resist 2009, 15:115-120.
26. Abay S., Kayman T., Otlu B., Hizlisoy H., Aydin F., Ertas N. Genetic diversity and antibiotic resistance profiles of Campylobacter jejuni isolates from poultry and humans in Turkey. Int J Food Microbiol 2014, 178:29-38.
27. Perez-Boto D., Garcia-Pena F.J., Abad-Moreno J.C., Echeita M.A. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli strains isolated from two early stages of poultry production. Microb Drug Resist 2013, 19:323-330.
28. Zhao S., Mukherjee S., Chen Y., Li C., Young S., Warren M., et al. Novel gentamicin resistance genes in Campylobacter isolated from humans and retail meats in the USA. J Antimicrob Chemother 2015, 70:1314-1321.
29. Shi X., Wu A., Zheng S., Li R., Zhang D. Molecularly imprinted polymer microspheres for solid-phase extraction of chloramphenicol residues in foods. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 850:24-30.
30. Yang J.R., Wu H.S., Chiang C.S., Mu J.J. Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005. BMC Infect Dis 2008, 8:151.
31. Papavasileiou E., Voyatzi A., Papavasileiou K., Makri A., Andrianopoulou I., Chatzipanagiotou S. Antimicrobial susceptibilities of Campylobacter jejuni isolates from hospitalized children in Athens, Greece, collected during 2004-2005. Eur J Epidemiol 2007, 22:77-78.
32. Gaudreau C., Boucher F., Gilbert H., Bekal S. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolates obtained in Montreal, Quebec, Canada, from 2002 to 2013. J Clin Microbiol 2014, 52:2644-2646.
33. Roberts M.C. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett 2008, 282:147-159.
34. Wang Y., Zhang M., Deng F., Shen Z., Wu C., Zhang J., et al. Emergence of multidrug-resistant Campylobacter species isolates with a horizontally acquired rRNA methylase. Antimicrob Agents Chemother 2014, 58:5405-5412.
35. Deng F., Wang Y., Zhang Y., Shen Z. Characterization of the genetic environment of the ribosomal RNA methylase gene erm(B) in Campylobacter jejuni. J Antimicrob Chemother 2015, 70:613-615.
36. Corcoran D., Quinn T., Cotter L., Fanning S. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int J Antimicrob Agents 2006, 27:40-45.
37. Lehtopolku M., Kotilainen P., Haanpera-Heikkinen M., Nakari U.M., Hanninen M.L., Huovinen P., et al. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2011, 55:5939-5941.
38. Rozynek E., Mackiw E., Kaminska W., Tomczuk K., Antos-Bielska M., Dzierzanowska-Fangrat K., et al. Emergence of macrolide-resistant Campylobacter strains in chicken meat in Poland and the resistance mechanisms involved. Foodborne Pathog Dis 2013, 10:655-660.
39. Moore S.D., Sauer R.T. Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22. Proc Natl Acad Sci U S A 2008, 105:18261-18266.
40. Lin J., Akiba M., Sahin O., Zhang Q. CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob Agents Chemother 2005, 49:1067-1075.
41. Cagliero C., Maurel M.C., Cloeckaert A., Payot S. Regulation of the expression of the CmeABC efflux pump in Campylobacter jejuni: identification of a point mutation abolishing the binding of the CmeR repressor in an in vitro-selected multidrug-resistant mutant. FEMS Microbiol Lett 2007, 267:89-94.
42. Perez-Boto D., Lopez-Portoles J.A., Simon C., Valdezate S., Echeita M.A. Study of the molecular mechanisms involved in high-level macrolide resistance of Spanish Campylobacter jejuni and Campylobacter coli strains. J Antimicrob Chemother 2010, 65:2083-2088.
43. Mamelli L., Prouzet-Mauleon V., Pages J.M., Megraud F., Bolla J.M. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005, 56:491-497.
44. Hwang S., Zhang Q., Ryu S., Jeon B. Transcriptional regulation of the CmeABC multidrug efflux pump and the KatA catalase by CosR in Campylobacter jejuni. J Bacteriol 2012, 194:6883-6891.
45. Mavri A., Smole Mozina S. Effects of efflux-pump inducers and genetic variation of the multidrug transporter cmeB in biocide resistance of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 2013, 62:400-411.
46. Hao H., Yuan Z., Shen Z., Han J., Sahin O., Liu P., et al. Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni. Antimicrob Agents Chemother 2013, 57:1369-1378.